Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis

Although direct‐acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection are highly efficacious and safe, treatment initiation is often limited in patients with neuropsychiatric disorders due to concerns over reduced treatment adherence and drug–drug interactions. Here, we report adher...

Descripción completa

Detalles Bibliográficos
Autores principales: Back, David, Belperio, Pamela, Bondin, Mark, Negro, Francesco, Talal, Andrew H., Park, Caroline, Zhang, ZhenZhen, Pinsky, Brett, Crown, Eric, Mensa, Federico J., Marra, Fiona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852431/
https://www.ncbi.nlm.nih.gov/pubmed/30977945
http://dx.doi.org/10.1111/jvh.13110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852431/
https://www.ncbi.nlm.nih.gov/pubmed/30977945
http://dx.doi.org/10.1111/jvh.13110

Ejemplares similares